Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium vs Calcium Hydroxide in Necrotic Pulp
NCT05582421Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of diclofenac in pulp necrosis and apical periodontitis (AP) (2 arms), sponsored by Cairo University. Primary endpoint: Intensity of postoperative pain at 48 hours. Status: unknown.
02
Drugs
diclofenac
03
Conditions
pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT05582421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05582421.